title: [Transcatheter aortic valve implantation (TAVI)].
abstract: Aortic valve stenosis (AS) is the most common acquired valve disease in the industrialized countries. Most patients--especially young and low-risk patients--can be safely and effectively operated with aortic valve replacement. Due to increasing life expectancy, however, the number of elderly patients with AS and various concomitant diseases will increase in the coming decades. For those elderly high-risk patients, transfemoral or transapical aortic valve implantation (TAVI) has evolved as a valuable alternative to conventional surgery. The TAVI approach has been shown to be superior to standard medical treatment in these high-risk patients. All patients considered for TAVI should be discussed in a consensus conference consisting of cardiac surgeons and cardiologists (heart team). Furthermore, for successful treatment with transcatheter techniques, sophisticated pre-interventional imaging is required to screen patients. Available data on TAVI from randomized trials and large-scale registries demonstrate that this method is very promising.
authors.affiliation: Abteilung für Kardiologie, Kerckhoff-Klinik Bad Nauheim, Benekestr. 2-8, 61231, Bad Nauheim, Deutschland, h.moellmann@kerckhoff-klinik.de.
authors.forename: H
authors.initials: H
authors.lastname: Möllmann
authors.forename: W-K
authors.initials: WK
authors.lastname: Kim
authors.forename: T
authors.initials: T
authors.lastname: Walther
authors.forename: C
authors.initials: C
authors.lastname: Hamm
mesh_terms: D001021:Aortic Valve / Q000601:surgery*; D000082882:Bicuspid Aortic Valve Disease; D006328:Cardiac Catheterization / Q000295:instrumentation*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006330:Heart Defects, Congenital / Q000601:surgery*; D006349:Heart Valve Diseases / Q000601:surgery*; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006801:Humans; D016896:Treatment Outcome